Pfizer Inc (NYSE:PFE) announced that it was ending the sale of its only vaccine drug in China. The company said the move resulted from the fact that it…

In past three years, the revenue of Pfizer Inc. (NYSE:PFE)’s Global Vaccines, Oncology & Consumer Healthcare (GVOC) Segment increased considerably…

MerkKGaA, the German pharma company, is in news again. This time it has partnered, with Intrexon Corp (NYSE:XON) on Cancer drug development project in…

While Pfizer Inc. (NYSE:PFE) has maintained the eventful activities in the M&As arena of drug-making companies, it is speculated that the next target…

Pfizer Inc. (NYSE:PFE) is known for its last year good records and business of $3.53 billion in selling treatments for rare diseases. These days the big…

While Pfizer Inc. (NYSE:PFE) and AstraZeneca plc (ADR) (NYSE:AZN) are still trying to enter the PD-1 market, Merck & Co., Inc. (NYSE:MRK) has already…

Pfizer Inc. (NYSE:PFE) was up the last day after the U.S. Food and Drug Administration allowed partial relief to the company’s Tanezumab, which is…

A recent study conducted on the Prevnar vaccine of Pfizer Inc. (NYSE:PFE) revealed that it acted as a savior to thousands of elders against serious infections….

Pfizer Inc. (NYSE:PFE) failed to find a cure to pain as its drug Lyrica returned negative study results. The drug under post-marketing study that aimed…

Pfizer Inc. (NYSE:PFE) is suffering from a mild correction so far after the FDA decided to maintain the warning of the company’s anti-smoking drug named…